ZTS

ZOETIS
D

ZTS

166.470
USD
-1.03
(-0.61%)
مفتوح الان
حجم التداول
30,418
الربح لكل سهم
6
العائد الربحي
1.07
P/E
31
حجم السوق
75,105,439,381
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
التوصيات
أصول ذات صلة
    NEOUSD
    NEOUSD
    -0.317
    (-2.18%)
    14.257 USD
    AMGN
    AMGN
    -0.45
    (-0.16%)
    274.35 USD
    BMY
    BMY
    0.060
    (0.11%)
    57.110 USD
    IDXX
    IDXX
    3.86
    (0.90%)
    430.96 USD
    MRK
    MRK
    -0.250
    (-0.26%)
    95.930 USD
    N
    NEO
    0.475
    (3.35%)
    14.660 USD
    NVS
    NVS
    -1.060
    (-1.06%)
    98.590 USD
    PFE
    PFE
    -0.416
    (-1.56%)
    26.165 USD
    SNY
    SNY
    -0.420
    (-0.81%)
    51.250 USD
    المزيد
الأخبار
المقالات

العنوان: ZOETIS

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.